See also this year's filing and all EDGAR filings for this company.
PDF Report 0001113148_2021_Infinity_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001113148, Infinity Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 36,020,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,710,000 |
| 3 | remainder_Assets | 1,589,000 |
| 4 | LiabilitiesCurrent | 11,047,000 |
| 5 | LiabilitiesNoncurrent | 1,681,000 |
| 6 | remainder_Liabilities | 49,580,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,972,827 |
| 9 | ResearchAndDevelopmentExpense | 26,682,520 |
| 10 | remainder_Expenses | 4,254,733 |
| 11 | remainder_Revenues | 2,150,227 |
| 12 | remainder_NetIncome | -1,829,287 |
| 13 | remainder_ComprehensiveNetIncome | -11,414 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 39,319,000 |
| 1 | Liabilities | 62,308,000 |
| 2 | Expenses | 42,910,080 |
| 3 | Revenues | 2,150,227 |
| 4 | StockholdersEquity | -22,989,000 |
| 5 | NetIncome | -42,589,140 |
| 6 | ComprehensiveNetIncome | -42,594,847 |
| 7 | BaseVar | 74,264,004 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.82 |
| 9 | EconomicCapitalRatio | 1.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
